Sperm-associated antigen 6 (SPAG6): roles in human cancer and other diseases
LI Qing-Lin1,2,3, ZHOU Peng-Zhan1,2, Lv Zhi-Yi1,2, LIU Han-Qi1,2, LIU Kang1, MEI Yang2,3,*
1The Affiliated Xiangtan Central Hospital of Hunan University, Xiangtan 411100, China;2School of Biomedical Sciences, Hunan University, Changsha 410082, China;3Greater Bay Area Institute for Innovation, Hunan University, Guangzhou 511300, China
Abstract
Emerging evidence indicates that sperm-associated antigen 6 (SPAG6), a protein initially characterized for its role in ciliogenesis and spermatogenesis, plays critical roles not only in the genital system but also in the nervous, immune, and hematopoietic systems. More recently, SPAG6 has been increasingly implicated in cancer progression and treatment. In this review, we systematically summarize the molecular characterization of SPAG6 and delineate its functional roles and pathophysiological mechanisms across multiple organ systems. We also review its therapeutic relevance in cancer management, especially in hematopoietic malignancy. Notably, SPAG6 was found to be aberrantly overexpressed in clinical myelodysplastic syndrome (MDS) patients and promote the proliferation of MDS-L cells. While functional discrepancies of SPAG6 across experimental models warrant further in-depth exploration, elucidating its mechanisms in disease pathogenesis could offer valuable insights for developing targeted therapies for human diseases.
Key words: SPAG6; developmental homeostasis; solid tumor; hematopoietic malignancy; myelodysplastic syndrome
Received: Accepted:
Corresponding author: 梅杨 E-mail:
DOI: 10.13294/j.aps.2026.0062
Citing This Article:
LI Qing-Lin, ZHOU Peng-Zhan, Lv Zhi-Yi, LIU Han-Qi, LIU Kang, MEI Yang. Sperm-associated antigen 6 (SPAG6): roles in human cancer and other diseases. Acta Physiol Sin 2026; 78 (4): 838-850